Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Identifying and Screening for Hepatic Encephalopathy Risk Factors
Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, delve into the complexities of hepatic encephalopathy, exploring the various risk factors that contribute to its development, such as alcohol-induced cirrhosis, sarcopenia, CNS medications, opioids, and other potential triggers.
Now Viewing
EP: 1.Identifying and Screening for Hepatic Encephalopathy Risk Factors
EP: 2.Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care
EP: 3.Implementing Evidence-Based Guidelines for Hepatic Encephalopathy Management
EP: 4.Addressing the Caregiver Burden in Hepatic Encephalopathy Management
EP: 5.Optimizing Care for Newly Diagnosed Hepatic Encephalopathy
EP: 6.Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration
EP: 7.Managing Adverse Events Associated with HE Therapies
EP: 8.Integrating Treatment Protocols and Community Pharmacy in HE Management
EP: 9.Promoting Adherence: Strategies for Maintaining HE Therapy
EP: 10.Empowering Pharmacists: Essential Insights for HE Management
EP: 11.Optimizing Transitions of Care for Hepatic Encephalopathy Patients
EP: 12.Collaborative Care: Key Stakeholders in HE Treatment and Recovery
EP: 13.Hepatic Encephalopathy: Critical Insights and Closing Thoughts
Recent Videos
Related Content
